PubHawk
Kaohsiung J Med Sci June 2023 PMID 36960852

Caffeic acid phenethyl ester reverses doxorubicin resistance in breast cancer cells via lipid metabolism regulation at least partly by suppressing the Akt/mTOR/SREBP1 pathway.

Lu-Chang Liang, Lei Zhao, Bo Yu, Han-Xiang Hu, Xu-Hua He, Yan-Min Zhang

Full text PDF Download social card

Mentions

2
Peak: 1 in Jul 2023
across 2 sources since Jul 2023

Extended reach

187
potential audience

Total likes

0

Video views

146

Mentions per month

Jul 2023 – Sep 2023

Where it's discussed

  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions reflect a cautious optimism, with phrases like 'promising approach' and 'potential to improve therapy' signaling interest. The tone remains analytical, referencing mechanisms like Akt/mTOR/SREBP1 pathway suppression and lipid metabolism, which demonstrates some level of engagement with the scientific content while overall impact remains moderate due to the preliminary nature of the findings.

AgreementModerate agreement

Most discussions seem to agree that the research presents promising mechanisms to overcome drug resistance in breast cancer, especially noting the role of CAPE in affecting lipid metabolism pathways.

InterestModerate interest

Participants show moderate curiosity about the scientific details and potential applications, but lack deep enthusiasm or skepticism overall.

EngagementModerate engagement

Comments include some mentions of molecular pathways and therapeutic implications, indicating a fair level of engagement, but few users delve into detailed scientific critique.

ImpactModerate impact

The conversations suggest that some see this as a meaningful step forward in cancer treatment strategies, although the overall influence on clinical practice is still uncertain.

Abstract in brief

  • Caffeic acid phenethyl ester (CAPE) can reverse doxorubicin resistance in breast cancer cells by inhibiting lipid metabolism.
  • CAPE achieves this partly by suppressing the Akt/mTOR/SREBP1 signaling pathway, which is involved in lipid regulation.
  • These findings suggest that CAPE has potential as an adjuvant treatment to improve chemotherapy effectiveness in breast cancer.
Read the full abstract

Top posts

Most liked on X and Bluesky
Mr Ribena
@MrRibena1 · X

@wangzaibibibi Look at this https://t.co/rQ8R3uBOdV.

Jul 22, 2023 · 42 followers View post →

All mentions

Mr Ribena
@MrRibena1 · X

@wangzaibibibi Look at this https://t.co/rQ8R3uBOdV.

Jul 22, 2023 · 42 followers View post →